VR as preparation for care as usual for patients with a panic disorder or social phobia.

Completed

• Conditions: Social phobia and panic disorder; 10002861

• Registration Number: NL-OMON48032
• Lead Sponsor: ProPersona (Nijmegen)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 24

Inclusion Criteria

- DSM-5 diagnosis: panic disorder or social phobia, measured with the MINI KID
(adolescents) or MINI (adults)
- Age between 12 and 18 (adolescents) of 18+

Exclusion Criteria

- patients are diagnosed with a severe depressive disorder for which they need
immediate treatment (measured with the MINI or MINI KID)
- patients are diagnosed with a psychosis for which they need immediate
treatment (measured with the MINI or MINI KID)
- Mental retardation (IQ below 70)
- Substance abuse or dependence or alcohol abuse or dependence
- Psychofarmacology is changed in the last 8 weeks

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- willingness to take part in exposure in vivo<br /><br>Measured with the Friedman-test (non-parametric).<br /><br>When they differ significantly we will use post-hoc analyses (Wilcoxon Signed<br /><br>Rank Test with a Bonferroni correction). </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Anxiety Expectancy, activation of anxiety, approachability and course of<br /><br>symptoms (anxiety/depression) will be visual reproduced as descriptive<br /><br>statistics. </p><br>